Skip to main content
Clinical Trials/EUCTR2008-003696-43-NL
EUCTR2008-003696-43-NL
Active, not recruiting
Not Applicable

Prevention of progression of duodenal adenomas to cancer in patients with familial adenomatous polyposis - Duodenal adenomas and cancer in patients with FAP

KWF Kankerbestrijding0 sitesStarted: November 11, 2008Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
KWF Kankerbestrijding

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients with FAP with duodenal adenomas Spigelman stage II and III, under regular controle in one of 4 participating University hospitals.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- History of cardiovascular incident
  • \- Cholelithiasis
  • \- History of gastric or duodenal ulcera
  • \- Allergic reaction to NSAIDs or UDCA
  • \- Renal function disturbance, creat clearance \<50ml/min
  • \- Liver function disturbance, albumin \<25g/l or Child\-Pugh\-score \> or \= 10
  • \- Use of NSAIDs or UDCA during enrolment
  • \- Cardiac patients NYHA class II\-IV
  • \- Age below 18 or above 70 years or incapable of signing informed consent

Investigators

Sponsor
KWF Kankerbestrijding

Similar Trials